AIDS Research and Human Retroviruses · 1995 · 22 citations · 40 references
Life SciencesCell BiologyImmunologyCellular ImmunologyImmunology Of Infectious DiseasesMolecular VirologyAntigen PresentationCell-mediated ImmunityCellular Immunity In InfectionT Cell ActivationT Cell BiologyT Cell DifferentiationCellular Adhesion MoleculesCellular Immune Response To VirusesHiv Infection ModelsLeukocyte Adhesion MoleculesMajor Histocompatibility Complex Surface ExpressionPhenotypic DifferentiationT Cell ImmunologyT-cell Immunophenotypes
To investigate whether HTLV-I infection, HIV-I infection, or HIV-I infection of HTLV-I-infected cells affect the expression of cellular surface molecules, an HTLV-I-infected T cell line derived from the H9 T cell line was established (H36). H9 cells uninfected or infected with HTLV-I were then infected with HIV-1. We have compared the density of different surface markers on these three infected H9 T cell lines. These markers consist of T cell-specific antigens (CD2, CD3, CD4, and CD8), activated T cell antigens (CD25 and CD71), major histocompatibility complex (MHC) antigens (class I and II), and adhesion molecules (LFA-1 and ICAM-1). The experiments reported in this article show that chronic HTLV-I infection, HIV-1 infection, and HIV-1 infection of HTLV-I-infected T cells modulate the expression of several immunologically important cell surface antigens. The nature and the extent of T lymphoid cell phenotypic modulation depend on the infecting virus. Furthermore, HTLV-I and HIV-1 interact with each other in the phenotypic modulation of coinfected cells.
40
Bernard J. Poiesz, Francis W. Ruscetti, Adi F. Gazdar et al. · Proceedings of the National Academy of Sciences · 1980 · 5.1K citations · Full text
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
Antoine Gessain, J C Vernant, L. Maurs et al. · The Lancet · 1985 · 2.9K citations